Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurostyle is a Singapore-based medical device company that designs, develops, manufactures, and distributes neurological diagnostic, monitoring, rehabilitation, and home-care devices. Its commercial portfolio includes EEG, ambulatory EEG, EMG, intraoperative monitoring, neuro-rehabilitation, pelvic floor stimulation, balance training, and cranial electrostimulation products. The company appears to be focused on neurology and neurorehabilitation rather than drug development, with nBETTER as its flagship brain-computer-interface-based post-stroke rehabilitation system. Neurostyle also emphasizes collaborations with research teams and institutes to translate advanced neurotechnology into marketable medical devices. Overall, it is best characterized as a private, commercially active neuro-medtech manufacturer serving healthcare providers and distributors, particularly from Singapore into ASEAN and selected international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurostyle.